Response to letter re: Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: a systematic review and meta-analysis.

Diogo Martins-Branco Guilherme Nader-Marta Chiara Molinelli Lieveke Ameye Evandro de Azambuja

Eur J Cancer

Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Academic Trials Promoting Team (ATPT), Rue Meylemeersch 90, 1070 Bruxelles, Belgium; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Medical Oncology Department, Rue Meylemeersch 90, 1070 Bruxelles. Belgium.

Published: September 2024

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ejca.2024.114195	DOI Listing

Publication Analysis

Top Keywords

response letter

letter ki-67

ki-67 neoadjuvant

neoadjuvant endocrine

endocrine therapy

therapy prognostic

prognostic biomarker

biomarker patients

patients er-positive/her2-negative

er-positive/her2-negative early

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!